All Studies

The polysaccharides from seeds of Glycyrrhiza uralensis ameliorate metabolic disorders and restructure gut microbiota in type 2 diabetic mice.

GUP from Glycyrrhiza uralensis improves glycemic control, reduces oxidative stress and liver lipid levels, enhances intestinal barrier, kidney function, and gut microbiota diversity in T2D mice. Dietary strategy for diabetes control and overall health improvement.

Ye J et al (2024).
Int J Biol Macromol.
PubMed:
38447833

Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug.

POL in TCM treats inflammation and tumors in the digestive system. Its diverse compounds have strong anti-inflammatory and anti-cancer effects. Important for potential medical advancements.

Shao G et al (2024).
J Ethnopharmacol.
PubMed:
38447616

Phillyrin improves myocardial remodeling in salt-sensitive hypertensive mice by reducing endothelin1 signaling.

Phillyrin from Forsythia suspensa protects the heart from strain caused by chronic hypertension. This study explores how phillyrin can prevent hypertension-induced myocardial remodeling in mice.

Luo Q et al (2024).
J Pharm Pharmacol.
PubMed:
38447186

The Incidence of Postoperative Complications Following Lumbar and Bone Marrow Punctures in Pediatric Anesthesia: Insights From APRICOT.

Researchers investigated complications during bone marrow aspirations and lumbar punctures in children with cancer. Understanding risks can improve safety and decision-making in pediatric oncology procedures.

Dagher K et al (2024).
J Pediatr Hematol Oncol.
PubMed:
38447107

Therapeutic potential of saffron in brain disorders: From bench to bedside.

Researchers found saffron and its compounds, especially crocin, show promise for treating neurological disorders like depression and Alzheimer's. They protect the brain by modulating neurotransmitters, reducing inflammation, and improving cognitive function. Consider using saffron-based therapies for brain health.

Bej E et al (2024).
Phytother Res.
PubMed:
38446350

Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer.

Study assessed Hedyotis diffusa Willd effects on CRC using network pharmacology & experimental validation. Identified potential targets, key genes, pathways, & validated anti-CRC effects in vitro. Important for developing new CRC treatments.

Yuan X et al (2024).
Naunyn Schmiedebergs Arch Pharmacol.
PubMed:
38446216